Showing results (1921-1930 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|May 27, 1999
Willingness to pay as a measure of health benefitsM V Bala, J A Mauskopf, L L WoodPharmacoeconomics|May 27, 1999
Are mental health services losing out in the US under managed care?D L JohnsonPharmacoeconomics|May 27, 1999
The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on CostsE J Beck, K Tolley, A Power, et al.Pharmacoeconomics|May 27, 1999
Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from the perspective of Statutory Health InsuranceP K Schädlich, E Huppertz, J G BrechtPharmacoeconomics|May 27, 1999
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthmaM P Rutten-van Mölken, E K van Doorslaer, M D TillPharmacoeconomics|May 27, 1999
Fosphenytoin. Pharmacoeconomic implications of therapyS M Holliday, P Benfield, G L PloskerPharmacoeconomics|June 3, 1999
The effect of managed care on prescription drug costs and benefitsA Lyles, F B PalumboPharmacoeconomics|June 3, 1999
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark IIG Samsa, D Edelman, M L Rothman, et al.Pharmacoeconomics|June 3, 1999
Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALSS J Ackerman, E M Sullivan, K M Beusterien, et al.Pharmacoeconomics|June 3, 1999
Approaches to missing data inference results from CaPSURE: an observational study of patients with prostate cancerD P Lubeck, D J Pasta, S C Flanders, et al.Pageof 336